Indian Journal of Pharmacology Home 

EDUCATION FORUM
[View FULLTEXT] [Download PDF]
Year : 2014  |  Volume : 46  |  Issue : 6  |  Page : 579--583

Endocan: A novel circulating proteoglycan

Arunava Kali1, K.S. Rathan Shetty2 
1 Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Puducherry, India
2 Department of Otorhinolaryngology, Mahatma Gandhi Medical College and Research Institute, Puducherry, India

Correspondence Address:
Arunava Kali
Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Puducherry
India

Endocan is a novel endothelium derived soluble dermatan sulfate proteoglycan. It has the property of binding to a wide range of bioactive molecules associated with cellular signaling and adhesion and thus regulating proliferation, differentiation, migration, and adhesion of different cell types in health and disease. An increase in tissue expression or serum level of endocan reflects endothelial activation and neovascularization which are prominent pathophysiological changes associated with inflammation and tumor progression. Consequently, endocan has been used as a blood-based and tissue-based biomarker for various cancers and inflammation and has shown promising results.


How to cite this article:
Kali A, Shetty KR. Endocan: A novel circulating proteoglycan .Indian J Pharmacol 2014;46:579-583


How to cite this URL:
Kali A, Shetty KR. Endocan: A novel circulating proteoglycan . Indian J Pharmacol [serial online] 2014 [cited 2020 Feb 26 ];46:579-583
Available from: http://www.ijp-online.com/article.asp?issn=0253-7613;year=2014;volume=46;issue=6;spage=579;epage=583;aulast=Kali;type=0